Turkish Journal of Nephrology
Original Article

Current Status of Renal Replacement Therapies in Turkey: Summary of Turkish Society of Nephrology Registry 2016 Report

1.

İstanbul Üniversitesi, Cerrahpaşa Tıp Fakültesi, İç Hastalıkları Anabilim Dalı, Nefroloji Bilim Dalı, İstanbul, Türkiye

2.

Ankara Üniversitesi, Ankara Tıp Fakültesi, İç Hastalıkları Anabilim Dalı, Nefroloji Bilim Dalı, Ankara, Türkiye

3.

Akdeniz Üniversitesi, Akdeniz Tıp Fakültesi, İç Hastalıkları Anabilim Dalı, Nefroloji Bilim Dalı, Antalya, Türkiye

Turkish J Nephrol 2018; 27: 133-139
DOI: 10.5262/tndt.2018.3329
Read: 474 Downloads: 237 Published: 31 January 2019

OBJECTIVE: The Turkish Society of Nephrology registry collects data on hemodialysis, peritoneal dialysis and transplantation on an annual basis. Registry reports are printed every year as a booklet and this is the 27th year of the registry reports. The registry is in close collaboration with international registries.

MATERIAL and METHODS: In this paper, data from the 2016 registry report are summarized and yearly trends in the management of end-stage renal disease are also provided.

RESULTS: The number of patients on renal replacement therapy is increasing. At the end of 2016, 74475 patients were on renal replacement therapy. The prevalence and incidence of end-stage renal disease was 933 and 140 per million population, respectively. Diabetes was the most important cause of end-stage renal disease. Hemodialysis (76.1%) was the most common type of treatment modality, followed by transplantation (19.2%) and peritoneal dialysis 4.7%).

CONCLUSION: End-stage renal disease is a very important and growing health problem for our country. The renal registry of the Turkish Society of Nephrology is one of the leading tools for providing current and sound data on this public health problem.

Files
EISSN 2667-4440